Nautilus Biotechnology Inc stock is traded at $2.37, with a volume of 2,387,646. It is up +12.86% in the last 24 hours and up +15.05% over the past month. Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. Its products includes: Proteome Analysis System, Reagent Kits, Software and analysis.
Previous Close:
$2.10
Open:
$2.16
24h Volume:
2,387,646
Relative Volume:
0.54
Market Cap:
$301.87M
Revenue:
-
Net Income/Loss:
-$57.09M
P/E Ratio:
-
EPS:
-$0.4517
Net Cash Flow:
-$51.43M
1W Performance:
+2.16%
1M Performance:
+15.05%
6M Performance:
-5.58%
1Y Performance:
+24.74%
1-Day Range:
$2.14$2.45
1-Week Range:
$2.10$2.54
52-Week Range:
$0.8411$4.31
Nautilus Biotechnology Inc Stock (NAUT) Company Profile
Name
Nautilus Biotechnology IncSector
HealthcareIndustry
BiotechnologyPhone
206-333-2001Address
2701 EASTLAKE AVE EAST, SEATTLE, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS